David L. Doering

Apoptosis as a Measure of Chemosensitivity to Cisplatin and Taxol Therapy in Ovarian Cancer Cell Lines

Randall K. Gibb, Douglas D. Taylor, Tina C. Wan et al. · Gynecologic Oncology · 1997 · 124 citations

Medicine, Apoptosis, Gynecology +9

Squamous Cell Carcinoma Antigen: Clinical Utility in Squamous Cell Carcinoma of the Uterine Cervix

Jo-Ann N. Bolli, David L. Doering, James Bosscher et al. · Gynecologic Oncology · 1994 · 94 citations

Tumoral Pathology, Cervical Cancer, Cervical Health +13

Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma.

David L. Doering, Danny Barnhill, Edward B. Weiser et al. · PubMed · 1989 · 83 citations

Endometrial Adenocarcinoma, Surgical Oncology, Tumoral Pathology +13

Aberrations in Normal Systemic Lipid Metabolism in Ovarian Cancer Patients

Çiçek Gerçel-Taylor, David L. Doering, Fredric B. Kraemer et al. · Gynecologic Oncology · 1996 · 52 citations

Medicine, Pathology, Gynecology +5

Small cell neuroendocrine carcinoma of the vagina

R. E. Joseph, Michael H. Enghardt, David L. Doering et al. · Cancer · 1992 · 45 citations